Overview

Prophylactic Minimally Invasive Surfactant Evaluation

Status:
Recruiting
Trial end date:
2027-07-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the question: Does prophylactic administration of exogenous surfactant in the delivery room, using a minimally-invasive technique, improve outcome in preterm infants 22-29 weeks' gestation compared to rescue treatment using the same technique?
Phase:
Phase 4
Details
Lead Sponsor:
NorthShore University HealthSystem
Collaborator:
Chiesi USA, Inc.
Treatments:
Poractant alfa